Benzodiazepine Use and Misuse Among Adults in the United States
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Goals were to determine the prevalence of benzodiazepine use (as prescribed and misuse), characterize misuse, and examine variation by age. METHODS: A cross-sectional analysis was conducted of 2015 and 2016 National Survey on Drug Use and Health data limited to adults ≥18 (N=86,186) and data from those respondents reporting benzodiazepine use (N=10,290). Measurements included past-year prescription benzodiazepine use and misuse ("any way a doctor did not direct"), substance use disorders, mental illness, and demographic characteristics. Misuse was compared between younger (18-49) and older (≥50) adults. RESULTS: A total of 30.6 million adults (12.6%) reported past-year benzodiazepine use-25.3 million (10.4%) as prescribed and 5.3 million (2.2%) misuse. Misuse accounted for 17.2% of overall use. Adults ages 50-64 had the highest prescribed use (12.9%). Those ages 18-25 had the highest misuse (5.2%), and those ages ≥65 had the lowest (.6%). Misuse and abuse of or dependence on prescription opioids or stimulants were strongly associated with benzodiazepine misuse. Benzodiazepine misuse without a prescription was the most common type of misuse, and a friend or relative was the most common source. Adults ages ≥50 were more likely than younger adults to use a benzodiazepine more often than prescribed and to use a benzodiazepine to help with sleep. CONCLUSIONS: Benzodiazepine use among U.S. adults was higher than previously reported, and misuse accounted for nearly 20% of use overall. Use by adults ages 50-64 now exceeds use by those ages ≥65. Patients also prescribed stimulants or opioids should be monitored for benzodiazepine misuse. Improved access to behavioral interventions for sleep or anxiety may reduce some misuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since benzodiazepines are among the most frequently prescribed drugs in the United States, treatments for BIND represent an urgent unmet medical need [25].”
From Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey (2023) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundMeta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
Woolcott, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.357 · Cited by 1,326 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundExplicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly: An Update
Beers, M. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440350031003 · Cited by 1,059 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundPark, T. W., Saitz, R., Ganoczy, D., Ilgen, M. A., & Bohnert, A. S. B. (2015) · BMJ · doi:10.1136/bmj.h2698 · Cited by 579
Help-seeking behaviour in men and women with common mental health problems: cross-sectional study
Oliver, M. I., Pearson, N., Coe, N., & Gunnell, D. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.4.297 · Cited by 558 · cited 1×
“This may further support the hypothesis that higher misuse is partially a function of limited access to a prescribed option—limited for younger patients due to lack of insurance and for men due to minimal disclosure of mental health concerns to providers (42).”
BackgroundBenzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
Background
Research works printed but not linked: 2
- Lipari RN, Williams M, Van Horn SL. Why Do Adults Misuse Prescription Drugs? 2017 7 27 In: The Center for Behavioral Health Statistics and Quality Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US) Available from: https://www.ncbi.nlm.nih.gov/books/NBK458284/ 28968046
- Center for Behavioral Health Statistics and Quality. (2016). 2015 National Survey on Drug Use and Health: Summary of the Effects of the 2015 NSDUH Questionnaire Redesign: Implications for Data Users. Substance Abuse and Mental Health Services Administration, Rockville, MD. 30199192
Cited by
Items 201–300 of 351
Benzodiazepine Misuse Among Health Care Workers: The Effect of Sleep Disorders on Work Performance
Roncero, C., Bravo-Grande, J. L., Andrés-Olivera, P., Peña, M. G., Lobato, C. T., González-Pelaez, P., Aguilar, L., Remón-Gallo, D., & González-Sánchez, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124266 · Cited by 2
“It is estimated that BZD misuse affects approximately 17.2% of users, with consumption without prescription being the most common misuse, often facilitated by a friend or patient [14].”
InfluentialPauwels, P., Haack, B., Toto, S., Seifert, J., Grohmann, R., Heinze, M., Zolk, O., Proskynitopoulos, P. J., Schneider, M., & Greiner, T. (2025) · Addiction Science & Clinical Practice · doi:10.1186/s13722-025-00579-6 · Cited by 3
“There is often a comorbid association between alcohol use disorder and SHA-SUD [16, 33].”
Maksimović, Ž., Stajić, M., & Lončar-Stojiljković, D. (2019) · Scripta Medica · doi:10.5937/scriptamed50-22426 · Cited by 2
McCabe, S. E., Schulenberg, J. E., Wilens, T. E., Schepis, T. S., McCabe, V. V., & Veliz, P. T. (2023) · Psychiatric Services · doi:10.1176/appi.ps.20220247 · Cited by 2
The Effects of Becoming a Physician on Prescription Drug Use and Mental Health Treatment
Anderson, D. M., Diris, R., Montizaan, R. M., & Rees, D. (2021) · National Bureau of Economic Research · doi:10.3386/w29536 · Cited by 2
Misuse of Prescription Medications among Individuals with Mobility Disability
Na, L., Hsieh, H., & Glassman, T. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2086696 · Cited by 1
“Among general adults, benzodiazepine misuse without a prescription was the most common type of misuse (Maust et al., 2019).”
BackgroundKoch, N. V., & Butterfield, R. J. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01936-z · Cited by 1
Primary neurology healthcare and prescription drug addiction
Polidar, P. (2022) · Neurologie pro praxi · doi:10.36290/neu.2022.001 · Cited by 1
Meade, M., Schultz, M., Radack, T. M., Michael, M., Hilibrand, A. S., Kurd, M. F., Hsu, V., Kaye, I. D., Schroeder, G. D., Kepler, C. K., et al. (2023) · Clinical Spine Surgery A Spine Publication · doi:10.1097/bsd.0000000000001481 · Cited by 1
“18 Still, there is con fl icting evidence on postoperative opioid consumption after spine surgery, with 6-month postoperative opioid consumption rates ranging from 1% to 12.7%.”
BackgroundInfluentialKorona-Bailey, J., Moses, J., & Mukhopadhyay, S. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2454653 · Cited by 2
“Self-treatment motives range from taking prescription opioids for pain to misusing benzodiaze-pines to alleviate stress or induce sleep (Schepis et al., 2020; Maust et al., 2019).”
Mixson, L. S., Venkataraman, A., Drumright, L. N., Whitney, B. M., Jenkins, W. D., Friedmann, P. D., Zule, W. A., Havens, J. R., Ruderman, S. A., Stopka, T. J., et al. (2025) · Substance Use & Addiction Journal · doi:10.1177/29767342251331701 · Cited by 1
Chapman, C. A., Povysheva, N. V., Johnson, J. W., & Jacob, T. C. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110624 · Cited by 2
“Issues associated with long-term BZD use include addiction potential, tolerance to the behavioral effects, drug dependence, and withdrawal (Janhsen et al., 2015; Maust et al., 2019; P ´ etursson, 1994).”
de Frutos, P. F., Sánchez, F. J. G., Mudarra-García, N., Roque-Rojas, F., Kakakhel, S. I., & Luordo, D. (2025) · Medical Sciences · doi:10.3390/medsci13030164 · Cited by 3
“Even without detailed temporal sequencing, the co-occurrence of these substances raises safety concerns: combined CNS depressants (e.g., BZDs and alcohol) increase risks of accidents, impaired academic functioning, and misuse [3,13,14].”
The Use of Benzodiazepines in the Elderly Population: Epidemiology, Risks and Withdrawal Management
Hertz, Z., & Barczak, S. (2025) · Eurasian Journal of Family Medicine · doi:10.33880/ejfm.2025140301 · Cited by 2
Preclinical evidence for a novel pharmacotherapeutic approach for treating benzodiazepine addiction
Berro, L. F., Cook, J. E., Moreira-Junior, E. D. C., Hembree, H. L., Comfort, V. L., Rüedi‐Bettschen, D., Platt, D. M., & Rowlett, J. K. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03762-0 · Cited by 1
“Treatment of benzodiazepine addiction will need to consider the different patterns of drug taking, such as misuse vs. having a use disorder [3, 33].”
Rosa, C. E. E.-D. L., Avalos-Salgado, F. A., Suárez-Rico, D. O., Zermeño-Ruiz, M., Cortez-Álvarez, C. R., & Escutia-Gutiérrez, R. (2026) · Pharmacy · doi:10.3390/pharmacy14010006 · Cited by 1
“Compared against the general population, BZD dependence levels are lower, between 6.6 and 6.8% [18]; however, in clinical settings where BZD agents are used to treat pain like our population, levels tend to be higher.”
InfluentialThe Rationale for, and Use of, Benzodiazepines for Insomnia
Singal, P., & Chopra, A. (2026) · Psychiatric Annals · doi:10.3928/00485713-20251202-03 · Cited by 1
Trends and patterns of medical stimulant use by US adults
Olfson, M., McClellan, C. B., Zuvekas, S. H., & Blanco, C. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03519-1 · Cited by 1
“The data are available at https://meps.ahrq.gov/data_stats/ download_data_ fi les.jsp.”
Böss, N., Koller, G., Adorjan, K., Haller, B., Eyer, P. D. F., & Geith, S. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02232-y · Cited by 1
“These patterns parallel international data [9] and general population trends, where benzodiazepine prescribing peaks in midlife while misuse is more common in young adults [35].”
Wessman, I. D., Wadsworth, L. P., Gudmundsson, L. S., Löve, Þ. J., Rögnvaldsson, S., Arnkelsson, G. B., Ólafsson, A., Þorsteinsdóttir, S., Gunnarsson, B. L., Sigurðardóttir, G. Á., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342075 · Cited by 1
“[59,61].”
Cadet, K., Brinzo, P., & Martins, S. S. (2026) · Addiction · doi:10.1111/add.70409 · Cited by 1
Chapter 8. Sedative, Hypnotic, and Anxiolytic Use and Use Disorder Among Older Adults
Chandrasekhara, S., & Yu, S.-J. S. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551968.lg08 · Cited by 1
Obstructive Sleep Apnea in the Elderly
Singh, P., Roux, F., & Thapa, S. (2026) · Respiratory medicine · doi:10.1007/978-3-032-29861-4_12 · Cited by 1
Kumar, H., Sahare, T., & Joshi, A. (2026) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2026.2715149 · Cited by 1
National Trends in Benzodiazepine Dispensing
Cruz, N., Samples, H., Crystal, S., Olfson, M., Xie, F., & Bushnell, G. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20251346 · Cited by 1
Rosa, J. C. D. S., Malgarin, I. B., Martins, M. G., Gonçalves, B. D. S., de Carvalho, M. B., Dondé, F. D. O., Teixeira, B. C., Gonçalves, A. F., & Marcelino, J. H. (2022) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v3i5.1498 · Cited by 24
“Apesar dos efeitos positivos dos BDZ na redução da ansiedade dos pacientes, esses medicamentos podem apresentar consequências potencialmente graves, como deficiências cognitivas e alterações psicomotoras.(15) Além disso, os efeitos causados pelo uso de BDZ podem ser ampliados pela tolerância e dependência, podendo lev…”
BackgroundWheeler, P. B., Miller-Roenigk, B. D., Jester, J. K., & Stevens-Watkins, D. J. (2022) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2022.2101575 · Cited by 1
“The majority of research examining nonmedical use of BZDs among African Americans indicate that African Americans report nonmedical use of BZDs less frequently compared to Whites (Cook et al., 2018; Kurtz et al., 2011, 2017; Maust et al., 2019; Rigg & Ford, 2014).”
Trends in drug use among young adult females: a 22-year retrospective analysis
Clifford, E., Kilgore, P. C. S. R., Cvek, U., Trutschl, M., Baker, S., Conrad, S. A., Arnold, T., & Korneeva, N. L. (2022) · Toxicology Communications · doi:10.1080/24734306.2022.2110201 · Cited by 1
“A recent study demonstrated that patients who identify as Non-Hispanic White are prescribed benzodiazepines more often [14, 15].”
BackgroundNiazi, S. K., Iqbal, M., Spaulding, A., Wood, C. M., Manochakian, R., Paulus, A., Ailawadhi, S., Brennan, E. A., Dabaja, M. A. K., & Sher, T. (2022) · Southern Medical Journal · doi:10.14423/smj.0000000000001481 · Cited by 1
“484 None 54 (57) 65 (68) 119 Anxious 6 (6) 5 (5) 11 Depressed 16 (17) 11 (11) 27 Anxious and depressed 19 (20) 15 (16) 34 ED visit 0.”
Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach
Kinney, K. L., Zheng, Y., Morris, M. C., Schumacher, J. A., Bhardwaj, S. B., & Rowlett, J. K. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1087879 · Cited by 1
“Benzodiazepines, which are associated with risk of serious adverse effects (5, 6), represent a significant public health burden (2).”
BackgroundInfluentialSubstance and Prescription Misuse in Military and Veteran Populations
Rachal, J., Schrader, C. C., Schindler, A., & Ridpath, V. (2023) · Springer eBooks · doi:10.1007/978-3-031-18009-5_17 · Cited by 1
d’Amours, M., Ettis, F., Ginefri, L., Lim, J., Yuan, A.-S. L. P., Fontaine, J., Wazzan, D., Williamson, D. R., & Dagenais‐Beaulé, V. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01063-z · Cited by 1
“Despite these risks, their use remains prevalent, with nearly 13% of adults aged 65 years and older using benzodiazepines, as per an American survey [8].”
BackgroundTomko, C. A., Schneider, K. E., Nestadt, D. F., Zemlak, J. L., & Sherman, S. G. (2023) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-023-01169-w · Cited by 1
“Non-medi-cal prescription benzodiazepine use has been shown to be more common among individuals who also use prescription opioids non-medically (Maust et al., 2019).”
The effect of substance misuse on HIV persistence in the CNS
LuPone, T., Duyne, R. V., O’Brien, E. V., Matt, S. M., Dampier, W., Nonnemacher, M. R., Wigdahl, B. L., Gaskill, P. J., & Klase, Z. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00022-5 · Cited by 1
Otufowora, A., Liu, Y., Okusanya, A., Ogidan, A. O., Okusanya, A., & Cottler, L. B. (2024) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2023.230226r2 · Cited by 1
“…46 ; the presence of pain due to physical disability and high prevalence of coprescription of both opioids and sedatives 15 – 17, 19, 47 may 52 Given that sedatives are often coprescribed with opioids 15 – 17, In this study we showed a positive relationship between anxiety/depression and…”
BackgroundDANO TEMPORAL DO USO DE BENZODIAZEPÍNICOS POR IDOSOS: REVISÃO BIBLIOGRÁFICA
da Silva, C. F., Raimundo, M. D. M., Miranda, R. L., Soprani, T., & Ronchi, S. N. (2024) · Revista Contemporânea · doi:10.56083/rcv4n6-115 · Cited by 2
DiPiro, N. D., Dismuke‐Greer, C. E., & Krause, J. S. (2024) · Spinal Cord · doi:10.1038/s41393-024-01030-4 · Cited by 1
Murphy, A. L., Sawires, K., Peltekian, S. M., Helwig, M., Macdonald, M., Martin‐Misener, R., Saini, B., Neyedli, H. F., Giacomantonio, C., & Gardner, D. M. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100538 · Cited by 1
Descans, F., Tarazona, V., & Bandt, D. D. (2025) · BJGP Open · doi:10.3399/bjgpo.2024.0176 · Cited by 1
Comment on “Do Benzodiazepines Cause Alzheimer’s Disease?”
Maust, D. T., & Wiechers, I. R. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20070989 · Cited by 1
Self-citationBorrelli, E. P. (2020) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/borrelli-eric-2020 · Cited by 1
Depression and Anxiety Disorders
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg003 · Cited by 1
Gründer, G. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21199-7.00004-0 · Cited by 1
Vukojević, J., Horvat, L., Papić, V., & Štajduhar, A. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70394 · Cited by 1
Pharmacological principles for safe benzodiazepine and Z-drug dose reduction
Horowitz, M., Lamberson, N., Brandt, J., Framer, A., Shapiro, B., Sørensen, A., Cadogan, C., Ritvo, A., & Taylor, D. (2026) · Psychological Medicine · doi:10.1017/s0033291726104887
IDENTIFICAÇÃO DO PORTADOR DE TRANSTORNO MENTAL AGUDO SOB O CONTEXTO DA SEGURANÇA DO PACIENTE
Blanco, A. N. D., & da Silva, R. F. A. (2019) · Cogitare Enfermagem · doi:10.5380/ce.v24i0.65490
Psychotropic medication use patterns in home-based primary care: A scoping review
Vadiei, N., Howe, C. L., Zerr, B., Ladziak, N., Fain, M. J., & Lee, J. K. (2020) · Mental Health Clinician · doi:10.9740/mhc.2020.09.282
Sedgewick, A. E., Connery, H. S., & Greenfield, S. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-44459-4_13
Women Overdosing in the Pandemic
O’Connor, P. (2022) · International Journal of Feminist Approaches to Bioethics · doi:10.3138/ijfab-15.1.10
Part I: Interactive case: Rational deprescribing of benzodiazepine receptor agonists for insomnia
Farrell, B. J. (2022) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1612
Preditores de estresse no trabalho e de uso do álcool entre docentes de uma universidade pública
Pereira, S. L. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.22.2022.tde-18082022-114019
Substance and Drug Abuse on Human Health; A Case Study of Youth in the USA
Miech, T. K., Myles, A. F., & Moore, C. M. (2022) · Journal of Medicine Nursing & Public Health · doi:10.53819/81018102t5139
Chapter 17. Substance-Related and Addictive Disorders
Mavandadi, S., & Oslin, D. W. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds17
Yong, S. L., Tan, H. J. R., Chemi, N. B., Mokhtar, S. S. S., Yee, W. N., Zamri, N. M. B. M., Sahidan, E. B., & Sue, K. T. (2022) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.18.6.26 · Cited by 1
Prevalence of benzodiazepine use disorder during hospitalization for alcohol detoxification
Leconte, G. C., Clergue‐Duval, V., Bloch, V., Barré, T., Amami, J., Bellivier, F., Questel, F., Vorspan, F., & Icick, R. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12888
“The data regarding the misuse and the adverse events of this class of drugs have mostly been gathered in the geriatric population, including the risk of falls, delirium [1], and possible increased incidence of neurodegenerative disorders in chronic users [2].”
BackgroundComorbidity in bipolar disorder, volume II
(2023) · Frontiers research topics · doi:10.3389/978-2-83251-906-6
Benzodiazepine use in the population aged 18 to 40 years in the municipality of Bijelo Polje
Bošković, V., Vlaović-Bošković, J., Mihaljević, O., Djordjević, J., Tomović, F., & Babovic, B. (2022) · PONS - medicinski casopis · doi:10.5937/pomc19-41492
Lewis, J. D., Swanberg, M. M., Bien, E., Porcelan, J., & Broderick, P. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-14372-4_6
Discriminative stimulus and reinforcing effects of diclazepam in rodents
Lee, W., Lee, J. W., Kim, S., Kim, J. M., Youn, D.-H., Park, S. H., Kwon, C., & Choi, S.-O. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173687
Eventos Toxicológicos Relacionados a Medicamentos em Mulheres de Idade Fértil Toxicological
Costa, Q. D. S., Alfieri, D. F., Rufino, J. V., Guidoni, C. M., & Girotto, E. (2023) · Revista Psicologia e Saúde · doi:10.20435/pssa.v15i1.2421
Hypnotic Dependence and Withdrawal
Brasil, I. S. P. S., & Hasan, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-50710-6_6
Singier, A. (2022) · theses.fr (ABES) · doi:10.70675/640a5b29zb5ebz4611z8c53z584592b3f281
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments
Serretti, A. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000547
Clinical pharmacist service promotes the improvement of medical quality
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4872-1
Preoperative management of medications for psychiatric disorders
Robles, C. R. F., Fernandez-Robles, C. G., & Oprea, A. D. (2024) · Panminerva Medica · doi:10.23736/s0031-0808.24.05151-6
Mazzella, M., Fallone, M., & Akinyemi, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_20
Sheehan, D. V. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as22
Lima, L. D. S., Pinto, S. O., & do Nascimento, H. D. D. S. (2024) · doi:10.22533/at.ed.35324080810
Ximenes, A. D. J., Pereira, E. Z. D. S., Reis, L. S., Eduardo, A. M. D. L. E. N., & Lima, A. D. L. (2024) · doi:10.22533/at.ed.3532408084
OS BENEFÍCIOS DA OZONIOTERAPIA EM PACIENTES PÓS COVID-19
da Silva, S. I., & Lima, R. L. A. (2024) · doi:10.22533/at.ed.3532408088
da Silva, D. P., Silva, M. M., & Lima, C. G. (2024) · doi:10.22533/at.ed.3532408086
Silva, E. O., Menezes, L. L., Santos, S. D. S., Eduardo, A. M. D. L. E. N., & Lima, A. D. L. (2024) · doi:10.22533/at.ed.3532408081 · Cited by 1
PLANTAS MEDICINAIS PARA O TRATAMENTO DA DEPRESSÃO: PLANTAS FITOTERÁPICAS
de Aguiar, A. O., Carvalho, E. D. S., da Silva, R. M., Eduardo, A. M. D. L. E. N., & Lima, A. D. L. (2024) · doi:10.22533/at.ed.3532408085
O USO DE PRODUTOS NATURAIS DA AMAZÔNIA EM COSMETOLOGIA
de Melo, A. L. P., Mamede, P. B. G., Vasconcellos, M. C., & Passos, M. F. (2024) · doi:10.22533/at.ed.35324080813 · Cited by 1
A EFICÁCIA DA ESPIRAMICINA NO TRATAMENTO DA TOXOPLASMOSE CONGÊNITA
Alfredy, R., Rocha, T., & Camargo, B. (2024) · doi:10.22533/at.ed.35324080812
A IMPORTÂNCIA DA ASSISTÊNCIA FARMACÊUTICA NA SAÚDE DO IDOSO USUÁRIO DE POLIFARMÁCIA
de Sousa, M. E. N., Oliveira, I. D. S., & de Araújo, B. G. (2024) · doi:10.22533/at.ed.3532408087
MALEFÍCIOS DO USO INDISCRIMINADO DO FENTANIL COMO DROGA RECREATIVA
Alves, D. A., Veras, K. D. S., Eduardo, A. M. D. L. E. N., & Lima, A. D. L. (2024) · doi:10.22533/at.ed.3532408083 · Cited by 1
Cunha, B. B., Jesus, A. D. F., & Davatz, G. C. (2024) · doi:10.22533/at.ed.35324080814
FARMACÊUTICO NA PRÁTICA DA VACINAÇÃO UM ESTUDO DA AÇÃO DE FARMACÊUTICOS NA VACINAÇÃO NO BRASIL
Loebens, D., Rosa, A. D. S., Cologni, G. F., de Souza, L. F. A., & Colacite, J. (2024) · doi:10.22533/at.ed.35324080811
O USO INDISCRIMINADO DE CORTICOIDES EM DIABÉTICOS TIPO 1
Soares, M. M., Arraes, M. L., da Silva, S. M., Eduardo, A. M. D. L. E. N., & Lima, A. D. L. (2024) · doi:10.22533/at.ed.3532408082
Safe Deprescribing of Benzodiazepines and Z‐drugs
(2024) · Wiley eBooks · doi:10.1002/9781394291052.mdg003
Erdős, Á. (2022) · Nemzeti Közszolgálati Egyetem · doi:10.17625/nke.2023.046 · Cited by 3
Passive Addiction and Teratogenic Effects
McPherson, C. C., Inder, T. E., & Volpe, J. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10513-5.00042-5
Psychoactive Medications in the ICU
Curran, S. P., John, K. B., & Bose, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-67069-5_9
Falise, A. M., Surendran, P. P., Hoeflich, C. C., Striley, C. W., LaMontagne, L. G., & Lopez‐Quintero, C. (2024) · American Journal on Addictions · doi:10.1111/ajad.13665
Coteur, K., Ryan, C. A., Smith, S. M., Sheaf, G., DeWert, M., Gardner, D. M., & Cadogan, C. A. (2024) · HRB Open Research · doi:10.12688/hrbopenres.13976.1
Influence of SSRI and SNRI co-prescription on benzodiazepine prescription trajectories
Kinney, K. L., Moreira-Junior, E. D. C., Berro, L. F., Morris, M. C., & Rowlett, J. K. (2025) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2025.100325
“Since their discovery in the early 1960s, benzodiazepines have been prescribed widely as therapeutic tools because of their anxiolytic, sedative, and anticonvulsant properties (Calcaterra and Barrow, 2014; Maust et al., 2019; Wick, 2013).”
Péter, L., Lázár, B. A., Bajsz, A., Bőthe, B., Paksi, B., Czakó, A., Griffiths, M. D., Horváth, Z., Demetrovics, Z., & Andó, B. (2025) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-025-01490-6
“Nevertheless, coping is a crucial motive for both substances, which may be explained by the fact that there are similarities between these substances and they often appear comorbidly (Blanco et al., 2018; Lopez et al., 2021; Maust et al., 2019).”
Health and Labor Market Consequences of Low-Value Care: The Role of Practice StylePreprint
Bakx, P., Mazzonna, F., & Albertini, M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5166533
IMPACTO DO USO PROLONGADO DE BENZODIAZEPÍNICOS NA SAÚDE FÍSICA E MENTAL DOS PACIENTES
Brasileiro, B. H. V., de Sousa, L. V. M., & Azevedo, P. S. D. S. (2025) · Revista Contemporânea · doi:10.56083/rcv5n5-021
Three essays in health economics
Gundavarapu, S. S. (2022) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/k824-74sh
Kaplan, K., Toennies, L. B., & Hunsberger, H. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-07380-0 · Cited by 1
Kauye, F., Wijesundara, A., & Mwandumba, D. (2025) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/0117450179375369250623061653
DeVaughn, A., Go, L. H. T., Bonney, T., Cohen, R. A., Shannon, B., Friedman, L. S., Richardson, D., Yan, R., & Almberg, K. S. (2025) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000003505
Impact of cannabis use on health outcomes and prescription benzodiazepine usePreprint
Singh, N., Dai, Y., Wilkinson, S. T., Rhee, T. G., & Radhakrishnan, R. (2025) · medRxiv · doi:10.1101/2025.08.23.25334295
Kasmirski, J. A., Song, Z., Swaminathan, N., Chaudhary, I., Balachandra, S., Gillis, A., Fazendin, J. M., Lindeman, B. M., & Chen, H. R. (2025) · Surgery · doi:10.1016/j.surg.2025.109867
Chapter 7. Sedatives, Hypnotics, or Anxiolytics
Blazes, C. K., & Leung, S. (2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550862.lg07
Metadata
- Authors
- Maust, D. T., Lin, L. A., & Blow, F. C.
- Affiliations
- University of Michigan (US)
- Venue
- Psychiatric Services
- Published
- 2019-02-01
- Volume
- 70
- Issue
- 2
- Pages
- 97-106
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- PMC
- PMC6358464
- OpenAlex
- W2904755589
- Cited by
- 337
- References
- 42
- Citations by year
- 2026: 40 · 2025: 50 · 2024: 72 · 2023: 48 · 2022: 56 · 2021: 27 · 2020: 35 · 2019: 8
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA045705)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepine misuse, benzodiazepine use, prescription drug misuse, prevalence, age differences, substance use disorders, opioid misuse, stimulant abuse, sleep aids, benzodiazepine dependence, National Survey on Drug Use and Health
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Benzodiazepines, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Drug Prescriptions, United States, Prevalence, Young Adult, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.